CTSO Cytosorbents Corporation - Common Stock
$0.36
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
CTSO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.36
市值
—
P/E (TTM)
-4.9
每股收益 (TTM)
$-0.13
营收 (TTM)
$37M
股息收益率
—
ROE
—
负债/权益
—
52周区间
$0 – $1
CTSO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$37M
2022-12-31
→
2025-12-31
EPS
$-0.13
2022-12-31
→
2025-12-31
自由现金流
—
2022-12-31
→
2024-12-31
利润率
—
2022-12-31
→
2024-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CTSO
同行中位数
P/E (TTM)
-4.9
27.5
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CTSO
同行中位数
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CTSO
同行中位数
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CTSO
同行中位数
Revenue YoY (营收同比增长)
4.1%
—
Revenue CAGR 3Y (营收3年复合年增长率)
2.2%
—
Revenue CAGR 5Y (营收5年复合年增长率)
-2.0%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CTSO
同行中位数
CTSO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
卖出
6 位分析师
- 强烈买入 0 0.0%
- 买入 0 0.0%
- 持有 3 50.0%
- 卖出 1 16.7%
- 强烈卖出 2 33.3%
12个月价格目标
1 位分析师 · 2026-08-13
最低
$5.00
最高
$5.00
中位数目标
$5.00
+1296.6%
平均目标
$5.00
+1296.6%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.00%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.07 | $-0.05 | -0.02% |
| 2026年3月31日 | $-0.08 | $-0.06 | -0.02% |
| 2025年12月31日 | $-0.09 | $-0.05 | -0.04% |
| 2025年9月30日 | $-0.05 | $-0.05 | -0.00% |
| 2025年6月30日 | $0.03 | $-0.05 | 0.08% |
| 2025年3月31日 | $-0.02 | $-0.07 | 0.05% |
| 2024年12月31日 | $-0.14 | $-0.06 | -0.08% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CTSO | — | -4.9 | 4.1% | — | — | — |
| BEAT | — | — | — | — | — | — |
| NMTC | — | -9.9 | 163.5% | — | — | — |
| ADGM | — | -0.7 | — | — | — | — |
| IRIX | $20M | -4.5 | 8.2% | -8.4% | -80.8% | 36.5% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37M | $36M | $31M | $35M | $43M | $41M | $25M | $23M | $15M | $10M | $5M | $4M | |
| Cost of Revenue | $11M | $11M | $9M | $14M | $11M | $11M | $7M | $7M | $6M | $4M | $2M | $2M | |
| Gross Profit | $26M | $25M | $22M | $21M | $32M | $30M | $18M | $15M | $10M | $6M | $3M | $2M | |
| R&D Expense | · | · | $16M | $15M | $16M | $9M | $12M | $8M | $3M | $4M | $4M | $2M | |
| SG&A Expense | $36M | $34M | $38M | $34M | $36M | $28M | $22M | $21M | $15M | $12M | $7M | $6M | |
| Operating Expenses | $41M | $41M | $54M | $52M | $55M | $40M | $37M | $31M | $19M | $17M | $12M | $9M | |
| Operating Income | $-15M | $-16M | $-32M | $-32M | $-23M | $-10M | $-19M | $-16M | $-10M | $-11M | $-9M | $-7M | |
| Other Non-op | $6M | $-6M | $2M | $-2M | $-3M | $1M | $-1M | $-2M | $705.1K | $-589.9K | $-498.0K | $-3M | |
| Pretax Income | $-9M | $-22M | $-30M | $-34M | $-25M | $-9M | $-20M | $-18M | $-9M | $-12M | $-10M | $-10M | |
| Income Tax | $-401.0K | $-2M | $-813.7K | $-1M | $-736.0K | $-1M | $-1M | $-619.5K | $-676.7K | $-318.6K | $-324.6K | $-385.6K | |
| Net Income | $-8M | $-21M | $-29M | $-33M | $-25M | $-8M | $-19M | $-17M | $-8M | $-12M | $-9M | $-9M | |
| EPS (Basic) | $-0.13 | $-0.38 | $-0.65 | $-0.75 | $-0.57 | $-0.20 | $-0.60 | · | · | · | · | · | |
| EPS (Diluted) | $-0.13 | $-0.38 | $-0.65 | $-0.75 | $-0.57 | $-0.20 | $-0.60 | · | · | · | · | · | |
| Shares (Basic) | 62,231,771 | 54,434,609 | 44,656,391 | 43,573,215 | 43,359,186 | 38,818,990 | 32,255,253 | · | · | · | · | · | |
| Shares (Diluted) | 62,231,771 | 54,434,609 | 44,656,391 | 43,573,215 | 43,359,186 | 38,818,990 | 32,255,253 | · | · | · | · | · | |
| EBITDA | · | $-17M | $-31M | $-32M | $-23M | $-10M | $-19M | $-16M | $-10M | $-11M | $-9M | $-7M |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $3M | $14M | $22M | $52M | $71M | $12M | $22M | $17M | $5M | $5M | $4M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | $0 | $2M | $2M | |
| Receivables | $8M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $2M | $1M | $648.9K | $819.2K | |
| Inventory | $5M | $3M | $3M | $3M | $5M | $3M | $2M | $833.1K | $795.7K | $834.0K | $1M | $537.6K | |
| Prepaid Expense | $2M | $3M | $2M | $2M | $3M | $3M | $2M | $1M | $416.0K | $315.8K | $511.9K | $700.5K | |
| Current Assets | $21M | $22M | $25M | $34M | $64M | $82M | $21M | $28M | $21M | $8M | $10M | $8M | |
| PP&E (Net) | $8M | $9M | $10M | $11M | $5M | $2M | $2M | $2M | $1M | $569.4K | $557.3K | $245.8K | |
| PP&E (Gross) | $13M | $13M | $13M | $13M | $10M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | |
| Accum. Depreciation | $5M | $4M | $3M | $2M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | |
| Intangibles | $3M | $4M | $4M | $4M | $5M | $4M | $3M | $3M | $2M | · | · | · | |
| Other Non-current Assets | $53.0K | $50.0K | $4M | $4M | $5M | $4M | $3M | $3M | $2M | $1M | $836.7K | $615.8K | |
| Total Assets | $44M | $47M | $53M | $63M | $90M | $90M | $27M | $34M | $24M | $10M | $11M | $8M | |
| Accounts Payable | $3M | $3M | $4M | $2M | $3M | $2M | $2M | $1M | $1M | $1M | $684.6K | $698.3K | |
| Accrued Liabilities | · | · | $497.6K | $850.6K | $1M | $631.6K | $629.2K | $479.8K | $310.2K | $44.9K | · | · | |
| Current Liabilities | $10M | $10M | $14M | $10M | $14M | $10M | $10M | $7M | $8M | $4M | $3M | $5M | |
| Capital Leases | $12M | $12M | $13M | $13M | $13M | $581.6K | $642.7K | $1M | · | · | · | · | |
| Total Liabilities | $38M | $36M | $29M | $28M | $27M | $11M | $24M | $17M | $14M | $8M | $3M | · | |
| Long-term Debt | $17M | · | $5M | · | · | $0 | $15M | $10M | $10M | $5M | $0 | · | |
| Total Debt | · | $14M | $5M | $5M | · | $0 | $15M | $10M | $10M | $5M | · | · | |
| Common Stock | $63.0K | $55.0K | $54.2K | $43.6K | $43.5K | $43.2K | $32.6K | $31.8K | $29.0K | $25.5K | $25.4K | $23.3K | |
| Paid-in Capital | $321M | $311M | $306M | $287M | $283M | $278M | $192M | $186M | $163M | $144M | $140M | $128M | |
| Retained Earnings | $-312M | $-304M | $-283M | $-254M | $-221M | $-197M | $-189M | $-170M | $-152M | $-144M | $-133M | $-124M | |
| AOCI | $-3M | $4M | $529.3K | $2M | $525.6K | $-2M | $526.0K | $288.2K | $-361.0K | $898.7K | $584.3K | $227.7K | |
| Stockholders' Equity | $6M | $11M | $23M | $35M | $63M | $79M | $3M | $17M | $10M | $1M | $10M | $7M | |
| Liabilities + Equity | $44M | $47M | $53M | $63M | $90M | $90M | $27M | $34M | $24M | $10M | $11M | $8M | |
| Shares Outstanding | 62,804,305 | 54,830,146 | 54,240,265 | 43,635,715 | 43,635,715 | 43,221,999 | 32,616,107 | 31,774,139 | 28,973,679 | 25,483,966 | 25,397,056 | 23,304,640 |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $882.6K | $731.6K | $660.8K | $581.5K | $390.6K | $218.3K | $161.6K | $113.0K | $65.5K | |
| Stock-based Comp | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $4M | $3M | $3M | $382.3K | $695.8K | |
| Amort. of Intangibles | $262.0K | $235.0K | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | $510.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-12M | $-14M | $-22M | $-28M | $-14M | $-6M | $-17M | $-11M | $-6M | $-7M | $-9M | $-6M | |
| CapEx | $164.0K | $284.0K | $538.1K | $6M | $4M | $708.4K | $698.2K | $672.0K | $990.7K | $140.7K | $403.6K | $153.2K | |
| Investing Cash Flow | $-415.0K | $-669.0K | $-936.2K | $-6M | $-4M | $-2M | $-2M | $-2M | $-2M | $2M | $-890.9K | $-2M | |
| Debt Issued | $2M | $15M | · | $5M | · | $1M | $5M | $666.7K | $5M | $5M | $0 | $0 | |
| Net Debt Issued | · | $10M | · | $5M | · | $-15M | $5M | $0 | $5M | $5M | · | · | |
| Stock Issued | · | · | · | · | $27M | $27M | $14M | $10M | $10M | · | · | · | |
| Net Stock Activity | · | · | · | · | $27M | $27M | $14M | $10M | $10M | · | · | · | |
| Financing Cash Flow | $9M | $9M | $14M | $5M | $715.2K | $66M | $8M | $17M | $20M | $5M | $12M | $10M | |
| Net Change in Cash | $-2M | $-6M | $-8M | $-30M | $-18M | $59M | $-10M | $5M | $12M | $-71.7K | $2M | $1M | |
| Taxes Paid | $-2M | $-881.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-15M | $-22M | $-34M | $-18M | $-6M | $-17M | $-12M | $-7M | $-7M | $-9M | $-7M |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 70.6% | 61.6% | 59.8% | 74.4% | 73.0% | 70.5% | 66.7% | 63.6% | 58.5% | 53.8% | 48.2% | |
| Operating Margin | · | -47.2% | -85.9% | -90.9% | -52.7% | -25.3% | -76.0% | -69.2% | -65.0% | -120.6% | -194.2% | -176.6% | |
| Net Margin | · | -58.2% | -78.4% | -94.6% | -56.9% | -19.1% | -77.2% | -76.5% | -55.8% | -125.3% | -169.7% | -226.1% | |
| Pretax Margin | · | -63.0% | -80.7% | -97.7% | -58.6% | -21.9% | -81.6% | -79.2% | -60.3% | -128.7% | -176.5% | -235.4% | |
| EBITDA Margin | · | -47.2% | -85.9% | -90.9% | -52.7% | -25.3% | -76.0% | -69.2% | -65.0% | -120.6% | -194.2% | -176.6% | |
| ROA | · | -43.5% | -56.5% | -43.0% | -27.4% | -13.4% | -62.6% | -60.6% | -50.1% | -114.0% | -82.5% | -149.0% | |
| ROE | · | -169.2% | -135.5% | -88.1% | -36.9% | -9.8% | -379.6% | -93.0% | -145.9% | -254.8% | -107.3% | 181.0% | |
| ROIC | · | -61.8% | -107.1% | -75.6% | -35.3% | -11.5% | -97.2% | -56.0% | -45.0% | -252.2% | -109.0% | -176.4% |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.2 | 1.8 | 3.5 | 4.7 | 8.1 | 2.1 | 4.3 | 2.6 | 1.3 | 3.2 | 1.7 | |
| Quick Ratio | · | 1.1 | 1.4 | 2.9 | 4.1 | 7.5 | 1.7 | 4.0 | 2.5 | 1.1 | 2.7 | 1.2 | |
| Debt / Equity | · | 1.3 | 0.2 | 0.1 | · | 0.0 | 4.4 | 0.6 | 1.0 | -10.4 | · | · | |
| LT Debt / Equity | · | 1.3 | 0.1 | 0.1 | · | 0.0 | 3.9 | 0.5 | 0.6 | -8.6 | · | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.7 | 0.7 | 0.5 | 0.5 | 0.7 | 0.8 | 0.8 | 0.9 | 0.9 | 0.5 | 0.7 | |
| Inventory Turnover | · | 3.5 | 4.2 | 3.4 | 3.0 | 4.6 | 5.0 | 9.2 | 6.8 | 3.9 | 2.6 | 5.4 | |
| Receivables Turnover | · | 5.3 | 6.2 | 6.8 | 8.9 | 8.5 | 5.9 | 7.3 | 8.3 | 9.2 | 6.5 | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.1% | 14.5% | -10.4% | -19.6% | 5.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.2% | -6.2% | -8.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $37M | $36M | $31M | $35M | $43M | $41M | $25M | $23M | $15M | $10M | $5M | $4M | |
| Net Income TTM | $-8M | $-21M | $-29M | $-33M | $-25M | $-8M | $-19M | $-17M | $-8M | $-12M | $-9M | $-9M | |
| Market Cap | · | $50M | $60M | $67M | $182M | $344M | $126M | $257M | $188M | $139M | $141M | $232M | |
| Enterprise Value | · | $61M | $51M | $50M | · | $273M | $128M | $244M | $181M | $139M | · | · | |
| P/E | -4.9 | -2.4 | -1.7 | -2.1 | -7.4 | -39.9 | -6.4 | -31.1 | -25.0 | -21.0 | -16.9 | · | |
| P/S | · | 1.4 | 1.9 | 1.9 | 4.2 | 8.4 | 5.0 | 11.4 | 12.4 | 14.6 | 29.5 | 56.2 | |
| P/B | · | 4.5 | 2.6 | 1.9 | 2.9 | 4.3 | 36.7 | 15.2 | 18.4 | -293.0 | 17.2 | 58.5 | |
| P / Tangible Book | 15.0 | 6.8 | 3.1 | 2.2 | 3.1 | 4.6 | · | · | · | · | · | · | |
| P / Cash Flow | · | -3.5 | -2.8 | -2.4 | -13.0 | -61.4 | -7.5 | -23.7 | -29.1 | -20.6 | -15.7 | -34.8 | |
| P / FCF | · | -3.4 | -2.7 | -2.0 | -10.3 | -54.5 | -7.2 | -22.3 | -25.3 | -20.2 | -15.0 | -34.0 | |
| EV / EBITDA | · | -3.6 | -1.6 | -1.6 | · | -26.3 | -6.8 | -15.7 | -18.4 | -12.1 | · | · | |
| EV / FCF | · | -4.1 | -2.3 | -1.5 | · | -43.2 | -7.4 | -21.2 | -24.3 | -20.2 | · | · | |
| EV / Revenue | · | 1.7 | 1.6 | 1.4 | · | 6.7 | 5.1 | 10.9 | 11.9 | 14.5 | · | · | |
| Earnings Yield | -20.3% | -41.8% | -58.6% | -48.4% | -13.6% | -2.5% | -15.6% | -3.2% | -4.0% | -4.8% | -5.9% | · |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $9M | $9M | $9M | $10M | $9M | $9M | $9M | $9M | $9M | $3M | $9M | $9M | $9M | $9M | $8M | |
| Cost of Revenue | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $-1M | $3M | $3M | $4M | $4M | $4M | |
| Gross Profit | $7M | $6M | $7M | $7M | $7M | $6M | $6M | $5M | $7M | $7M | $5M | $6M | $6M | $5M | $6M | $4M | |
| R&D Expense | $1M | $1M | · | · | $1M | $2M | · | $2M | $2M | $2M | · | $4M | $4M | $4M | $3M | $3M | |
| SG&A Expense | $8M | $8M | $9M | $9M | $9M | $8M | $8M | $8M | $9M | $9M | $14M | $8M | $8M | $8M | $8M | $9M | |
| Operating Expenses | $10M | $9M | $11M | $10M | $10M | $10M | $10M | $10M | $10M | $12M | $15M | $13M | $13M | $13M | $12M | $13M | |
| Operating Income | $-3M | $-3M | $-4M | $-3M | $-4M | $-4M | $-3M | $-5M | $-4M | $-5M | $-10M | $-7M | $-7M | $-8M | $-6M | $-9M | |
| Other Non-op | $-2M | $-2M | $-1M | $-709.0K | $6M | $2M | $-6M | $2M | $-724.0K | $-1M | $3M | $-2M | $406.2K | $565.7K | $4M | $-3M | |
| Pretax Income | · | · | $-5M | $-4M | · | $-1M | $-9M | $-3M | $-4M | $-6M | $-7M | $-9M | $-6M | $-7M | $-2M | $-12M | |
| Income Tax | $0 | $0 | $0 | $-401.0K | $0 | $0 | $-2M | $0 | $0 | $0 | $-813.7K | $0 | · | · | $-1M | $0 | |
| Net Income | $-4M | $-5M | $-5M | $-3M | $2M | $-1M | $-8M | $-3M | $-4M | $-6M | $-7M | $-9M | $-6M | $-7M | $-766.1K | $-12M | |
| EPS (Basic) | $-0.07 | $-0.08 | $-0.09 | $-0.05 | $0.03 | $-0.02 | $-0.14 | $-0.05 | $-0.08 | $-0.11 | $-0.13 | $-0.21 | $-0.15 | $-0.17 | $-0.02 | $-0.28 | |
| EPS (Diluted) | $-0.07 | $-0.08 | $-0.09 | $-0.05 | $0.03 | $-0.02 | $-0.14 | $-0.05 | $-0.08 | $-0.11 | $-0.13 | $-0.21 | $-0.15 | $-0.17 | $-0.02 | $-0.28 | |
| Shares (Basic) | 62,806,694 | 62,738,827 | -123,862,715 | 62,753,959 | 62,608,598 | 60,731,929 | -108,759,047 | 54,453,006 | 54,306,041 | 54,434,609 | -87,409,393 | 44,373,969 | 44,015,380 | 43,676,435 | -87,082,192 | 43,606,980 | |
| Shares (Diluted) | 62,806,694 | 62,738,827 | -128,420,494 | 62,753,959 | 67,166,377 | 60,731,929 | -108,759,047 | 54,453,006 | 54,306,041 | 54,434,609 | -87,409,393 | 44,373,969 | 44,015,380 | 43,676,435 | -87,082,192 | 43,606,980 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-4M | $-4M | · | $-4M | $-3M | $-5M | · | $-7M | $-7M | $-8M | · | $-9M |
资产负债表 25
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $5M | $6M | $8M | $10M | $12M | $3M | $6M | $8M | $9M | $14M | $8M | $13M | $19M | $22M | $23M | |
| Receivables | $7M | $7M | $8M | $7M | $8M | $8M | $7M | $7M | $8M | $7M | $6M | $6M | $7M | $6M | $6M | $5M | |
| Inventory | $4M | $4M | $5M | $4M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $2M | $2M | $3M | $4M | |
| Prepaid Expense | $852.0K | $1M | $2M | $2M | $1M | $3M | $3M | $1M | $1M | $880.4K | $2M | $2M | $1M | $2M | $2M | $1M | |
| Current Assets | $16M | $18M | $21M | $21M | $23M | $25M | $22M | $17M | $22M | $20M | $25M | $19M | $24M | $28M | $34M | $32M | |
| PP&E (Net) | $7M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $10M | $10M | $10M | $11M | $11M | $11M | $11M | |
| PP&E (Gross) | $13M | $13M | $13M | $13M | $13M | $13M | $13M | · | · | · | $13M | · | · | · | $13M | · | |
| Accum. Depreciation | $6M | $5M | $5M | $5M | $5M | $5M | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | $3M | $3M | $3M | $4M | $4M | $4M | $4M | · | · | · | $4M | · | · | · | $4M | · | |
| Other Non-current Assets | $53.0K | $52.0K | $53.0K | $4M | $4M | $4M | $50.0K | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | |
| Total Assets | $38M | $41M | $44M | $46M | $48M | $51M | $47M | $48M | $53M | $47M | $53M | $48M | $52M | $57M | $63M | $62M | |
| Accounts Payable | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $850.6K | · | |
| Current Liabilities | $24M | $16M | $10M | $10M | $10M | $10M | $10M | $8M | $10M | $13M | $14M | $12M | $10M | $10M | $10M | $10M | |
| Capital Leases | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | |
| Total Liabilities | $39M | $38M | $38M | $37M | $36M | $36M | $36M | $35M | $37M | $28M | $29M | $29M | $28M | $29M | $28M | $23M | |
| Long-term Debt | $17M | $17M | · | · | · | · | · | $14M | $14M | $4M | $5M | $5M | $5M | $5M | · | · | |
| Total Debt | $17M | $17M | · | $15M | $14M | $14M | · | $14M | $14M | $4M | · | $5M | $5M | · | · | · | |
| Common Stock | $63.0K | $63.0K | $63.0K | $63.0K | $63.0K | $62.5K | $55.0K | $54.5K | $54.3K | $54.3K | $54.2K | $44.4K | $44.2K | $43.9K | $43.6K | $43.6K | |
| Paid-in Capital | $322M | $322M | $321M | $320M | $319M | $318M | $311M | $308M | $308M | $306M | $306M | $292M | $290M | $289M | $287M | $286M | |
| Retained Earnings | $-322M | $-317M | $-312M | $-307M | $-304M | $-305M | $-304M | $-295M | $-293M | $-289M | $-283M | $-277M | $-267M | $-261M | $-254M | $-253M | |
| AOCI | $-996.0K | $-2M | $-3M | $-4M | $-4M | $2M | $4M | $-156.9K | $2M | $2M | $529.3K | $3M | $1M | $2M | $2M | $6M | |
| Stockholders' Equity | $-751.0K | $2M | $6M | $9M | $12M | $15M | $11M | $13M | $17M | $19M | $23M | $19M | $24M | $29M | $35M | $39M | |
| Liabilities + Equity | $38M | $41M | $44M | $46M | $48M | $51M | $47M | $48M | $53M | $47M | $53M | $48M | $52M | $57M | $63M | $62M | |
| Shares Outstanding | 62,842,748 | 62,733,305 | 62,804,305 | 62,794,305 | 62,610,376 | 62,529,466 | 54,830,146 | 54,500,613 | 54,306,415 | 54,293,555 | 54,240,265 | 43,851,380 | 43,851,380 | 43,851,380 | 43,635,715 | 43,634,845 |
现金流 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $97.0K | $364.0K | $404.5K | $368.5K | $154.0K | $383.1K | $400.7K | $397.3K | $391.3K | $407.2K | $402.0K | $258.6K | $223.2K | $213.1K | |
| Stock-based Comp | $368.0K | $544.0K | $887.6K | $488.0K | $571.0K | $818.0K | $920.5K | $891.0K | $989.0K | $959.5K | $2M | $1M | $570.2K | $830.3K | $869.4K | $1M | |
| Amort. of Intangibles | $60.0K | $61.0K | · | · | $60.0K | $63.0K | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | $270.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-583.0K | $-1M | $-5M | $-3M | $-2M | $-3M | $-2M | $-2M | $-5M | $-5M | $-6M | $-5M | $-7M | $-3M | $-5M | $-7M | |
| CapEx | $14.0K | $11.0K | $108.0K | $17.0K | $36.9K | $2.0K | $69.0K | $152.0K | $17.8K | $45.2K | $95.5K | $142.4K | $-209.4K | $509.7K | $213.4K | $639.8K | |
| Investing Cash Flow | $7.0K | $-46.0K | $-291.0K | $55.0K | $-131.8K | $-47.0K | $-124.0K | $-298.1K | $-119.0K | $-127.0K | $-135.9K | $-257.7K | $140.3K | $-682.9K | $-206.1K | $-716.5K | |
| Debt Issued | · | · | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-625.0K | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $53.2K | · | · | · | $641.7K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $53.2K | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $2M | $0 | $-1.1K | $7M | $167.0K | $-98.9K | $10M | $-571.8K | $12M | $648.3K | $931.1K | $684.3K | $5M | $0 | |
| Net Change in Cash | $-400.0K | $-1M | $-1M | $-3M | $-1M | $3M | $-2M | $-3M | $5M | $-6M | $6M | $-5M | $-6M | $-3M | $-407.7K | $-8M | |
| Free Cash Flow | · | $-1M | · | · | · | $-3M | · | · | · | $-5M | · | · | · | $-4M | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.2% | 69.2% | · | 70.3% | 70.9% | 71.1% | · | 56.2% | 65.7% | 67.1% | · | 63.6% | 63.9% | 57.7% | · | 44.6% | |
| Operating Margin | -27.4% | -34.3% | · | -30.2% | -37.6% | -44.5% | · | -46.8% | -34.5% | -50.3% | · | -83.4% | -69.6% | -83.5% | · | -111.2% | |
| Net Margin | -45.9% | -57.9% | · | -33.4% | 20.2% | -16.9% | · | -24.9% | -41.9% | -65.0% | · | -104.3% | -65.3% | -77.5% | · | -150.4% | |
| Pretax Margin | · | · | · | -37.6% | · | -16.9% | · | -24.9% | -41.9% | -65.0% | · | -104.3% | -65.3% | -77.5% | · | -150.4% | |
| EBITDA Margin | -27.4% | -34.3% | · | -30.2% | -37.6% | -44.5% | · | -46.8% | -34.5% | -50.3% | · | -83.4% | -69.6% | -83.5% | · | -111.2% | |
| ROA | -10.3% | -11.2% | · | -6.8% | 3.8% | -3.0% | · | -4.9% | -7.8% | -12.2% | · | -16.7% | -10.0% | -10.4% | · | -15.5% | |
| ROE | -81.5% | -61.3% | · | -28.8% | 13.8% | -8.8% | · | -14.8% | -20.3% | -26.6% | · | -31.9% | -17.2% | -17.4% | · | -22.2% | |
| ROIC | · | · | · | -10.8% | · | -13.5% | · | -16.4% | · | · | · | · | · | · | · | -23.0% |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 1.1 | · | 2.1 | 2.3 | 2.6 | · | 2.0 | 2.1 | 1.5 | · | 1.6 | 2.3 | 2.7 | · | 3.2 | |
| Quick Ratio | 0.5 | 0.7 | · | 1.5 | 1.8 | 2.0 | · | 1.5 | 1.6 | 1.1 | · | 1.2 | 1.9 | 2.4 | · | 2.7 | |
| Debt / Equity | -23.0 | 7.7 | · | 1.6 | 1.2 | 1.0 | · | 1.1 | 0.8 | 0.2 | · | 0.3 | 0.2 | · | · | · | |
| LT Debt / Equity | -4.1 | 4.7 | · | 1.6 | 1.2 | 1.0 | · | 1.1 | 0.8 | 0.1 | · | 0.2 | 0.2 | · | · | · |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.7 | 0.7 | · | 1.3 | 1.1 | 1.2 | · | 1.0 | 1.0 | 1.1 | · | 1.1 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.5 | 1.3 | 1.6 | · | 1.6 | 1.5 | 1.9 | · | 1.6 |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $38M | $37M | · | $36M | $36M | $35M | · | $35M | $35M | $36M | · | $37M | $36M | $35M | · | $36M | |
| Net Income TTM | $-11M | $-8M | · | $-5M | $-7M | $-15M | · | $-22M | $-26M | $-29M | · | $-35M | $-37M | $-39M | · | $-38M | |
| Market Cap | $24M | $36M | · | $59M | $80M | $63M | · | $82M | $38M | $52M | · | $82M | $157M | $148M | · | $59M | |
| Enterprise Value | $36M | $48M | · | $66M | $84M | $65M | · | $90M | $43M | $47M | · | $79M | $149M | · | · | · | |
| P/E | -2.2 | -4.7 | · | -10.4 | -10.7 | -3.8 | · | -4.2 | -1.4 | -1.6 | · | -3.4 | -5.8 | -4.7 | · | -1.4 | |
| P/S | 0.6 | 1.0 | · | 1.6 | 2.2 | 1.8 | · | 2.3 | 1.1 | 1.4 | · | 2.2 | 4.3 | 4.2 | · | 1.6 | |
| P/B | -31.3 | 16.2 | · | 6.5 | 6.9 | 4.3 | · | 6.3 | 2.3 | 2.7 | · | 4.5 | 6.5 | 5.1 | · | 1.5 | |
| P / Tangible Book | · | · | · | 10.8 | 10.2 | 5.8 | · | 6.3 | 2.3 | 2.7 | · | 4.5 | 6.5 | 5.1 | · | 1.5 | |
| P / Cash Flow | · | -30.6 | · | · | · | -18.0 | · | · | · | -10.7 | · | · | · | -47.5 | · | · | |
| P / FCF | · | -30.3 | · | · | · | -18.0 | · | · | · | -10.6 | · | · | · | -40.8 | · | · | |
| EV / EBITDA | -13.8 | -15.7 | · | -22.9 | -23.3 | -16.8 | · | -20.4 | -12.7 | -9.6 | · | -10.8 | -22.8 | · | · | · | |
| EV / FCF | · | -40.6 | · | · | · | -18.8 | · | · | · | -9.7 | · | · | · | · | · | · | |
| EV / Revenue | 1.0 | 1.3 | · | 1.8 | 2.4 | 1.9 | · | 2.6 | 1.2 | 1.3 | · | 2.1 | 4.1 | · | · | · | |
| Earnings Yield | -45.5% | -21.2% | · | -9.6% | -9.4% | -26.0% | · | -24.0% | -74.0% | -62.1% | · | -29.3% | -17.3% | -21.4% | · | -72.8% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 收入 | $37M | $36M | — | — | — |
| 毛利率 % | — | 70.6% | — | — | — |
| 营业利润率 % | — | -47.2% | — | — | — |
| 净收入 | $-8M | $-21M | — | — | — |
| 稀释后每股收益 (EPS) | $-0.13 | $-0.38 | — | — | — |
资产负债表
| 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | — | 1.3 | — | — | — |
| 流动比率 | — | 2.2 | — | — | — |
| 速动比率 | — | 1.1 | — | — | — |
现金流
| 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 自由现金流 | — | $-15M | — | — | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 56 家申报者 · $6.3M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 11 (+4 与上一季度对比) | 6 (-1 与上一季度对比) | 11 (+1 与上一季度对比) | 11 (+3 与上一季度对比) | +2.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 23 位内幕人士 · 9 位高管 · 8 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Phillip P. Chan | Chief Executive Officer | 2026年6月15日 P | 1744432 | 2 | 0 | $104897 |
| Peter J Mariani | Chief Financial Officer | 2026年6月15日 P | 638113 | 1 | 0 | $44000 |
| Kathleen P. Bloch | Chief Financial Officer | 2024年4月2日 A | 532941 | 0 | 0 | $0 |
| Ronald Berger | Interim CFO | 2013年4月4日 A | — | 0 | 0 | $0 |
| David Lamadrid | Chief Financial Officer | 2011年9月6日 M | 7837500 | 0 | 0 | $0 |
| Vincent Capponi | President and COO | 2025年8月8日 A | 766268 | 0 | 0 | $0 |
| Efthymios Deliargyris | Chief Medical Officer | 2025年8月8日 A | 473025 | 0 | 0 | $0 |
| Eric R. Mortensen | Chief Medical Officer | 2019年8月14日 M | 148932 | 0 | 0 | $0 |
| Robert Hawes Bartlett | Chief Medical Officer | 2017年2月24日 A | 30000 | 0 | 0 | $0 |
| Jiny Kim | 董事 | 2025年8月8日 A | 77819 | 0 | 0 | $0 |
| Michael G. Bator | 董事 | 2025年8月8日 A | 151273 | 0 | 0 | $0 |
| Alan D. Sobel | 董事 | 2025年8月8日 A | 145757 | 0 | 0 | $0 |
| Edward Raymond Jones | 董事 | 2025年8月8日 A | 88834 | 0 | 0 | $0 |
| Kraus Al | 董事 | 2023年2月6日 M | 142046 | 0 | 0 | $0 |
| James T. Gunton | 董事 | 2015年4月8日 A | 55000 | 0 | 0 | $0 |
| Joseph Rubin | 董事 | 2014年3月28日 A | 167213 | 0 | 0 | $0 |
| NJTC INVESTMENT FUND, LP | 10% 所有者 | 2015年4月8日 A | 2554999 | 0 | 0 | $0 |
| James F Winchester | — | 2008年6月25日 A | — | 0 | 0 | $0 |
| Kurt Katz | — | 2008年6月25日 A | — | 0 | 0 | $0 |
| MILLER WILLIAM R | — | 2008年6月25日 A | — | 0 | 0 | $0 |
| Martin F Whalen | — | 2007年12月31日 A | — | 0 | 0 | $0 |
| Margie Chassman | — | 2006年10月28日 J | 4795000 | 0 | 0 | $0 |
| Joseph G Bowes | — | 2006年7月6日 C | 0 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Guillermina Vega Montiel | 2006年7月24日 | — | 初始申报 | — | SEC |
| Joseph Bowes | 2006年7月13日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 3 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。